Prescription Drug News and Research

RSS
Buck survey finds health care costs projected to increase in 2011

Buck survey finds health care costs projected to increase in 2011

Prescription Solutions' MS DTM program wins URAC Best Practices Platinum Award

Prescription Solutions' MS DTM program wins URAC Best Practices Platinum Award

Research roundup: Examining comparative effectiveness research and changes in Medicare Part D

Research roundup: Examining comparative effectiveness research and changes in Medicare Part D

Meridia – weight loss pill off the shelves in US

Meridia – weight loss pill off the shelves in US

Firm sees drugs sales rising 5 to 7 percent next year, other drug industry news

Firm sees drugs sales rising 5 to 7 percent next year, other drug industry news

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

Humana Pharmacy agrees to highest standards of transparency for prescription-drug pricing

AstraZeneca provides free medicines to patients at Primary Care Center Pharmacy in Sacramento

AstraZeneca provides free medicines to patients at Primary Care Center Pharmacy in Sacramento

3.5 million Calif. residents eligible for tax credits in future exchange; N.Y. prescription drug aid for seniors cut back; Idaho trims dental providers in Medicaid

3.5 million Calif. residents eligible for tax credits in future exchange; N.Y. prescription drug aid for seniors cut back; Idaho trims dental providers in Medicaid

USP announces revision schedule for Model Guidelines Version 5.0

USP announces revision schedule for Model Guidelines Version 5.0

Sebelius: Medicare Advantage cuts won't hurt plans

Sebelius: Medicare Advantage cuts won't hurt plans

Care Improvement Plus releases 2011 Medicare health plan benefits to improve quality of care

Care Improvement Plus releases 2011 Medicare health plan benefits to improve quality of care

Australian reimbursement committee is set to consider Novo Nordisk's type 2 diabetes treatment

Australian reimbursement committee is set to consider Novo Nordisk's type 2 diabetes treatment

Mandatory contraceptive policy in clinical trials is excessive and can safely be relaxed

Mandatory contraceptive policy in clinical trials is excessive and can safely be relaxed

Some Minn. insurers will end certain Medicare plans; Utah issues rule on child-only plans; Fla. law on pain clinics takes effect

Some Minn. insurers will end certain Medicare plans; Utah issues rule on child-only plans; Fla. law on pain clinics takes effect

Sebelius tells seniors that 'outrageous claims' have clouded impressions of new law

Sebelius tells seniors that 'outrageous claims' have clouded impressions of new law

Bloomberg analysis finds 'doughnut hole' deal to cost drugmakers less than 1% of profits

Bloomberg analysis finds 'doughnut hole' deal to cost drugmakers less than 1% of profits

New co-branded Medicare Part D prescription drug plan from Humana and Walmart

New co-branded Medicare Part D prescription drug plan from Humana and Walmart

Health reform law bubbling up as campaign issue

Health reform law bubbling up as campaign issue

Canadian Cancer Society alarmed by government inaction to establish national catastrophic drug insurance program

Canadian Cancer Society alarmed by government inaction to establish national catastrophic drug insurance program

NABP seeks to educate public about rogue Internet drug outlets, counterfeit medications

NABP seeks to educate public about rogue Internet drug outlets, counterfeit medications

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.